ArticleBreast cancer research : BCR2026

Neoadjuvant anthracycline-free versus anthracycline-containing chemotherapy combined with dual HER2 blockade in HER2-positive breast cancer: a real-world comparative study.

Asli Buyukkuscu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.